Cetuximab Fab in complex with CQFDA(Ph)2STRRLKC
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| D | | e5t1kD1 | A: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | X: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | H: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | T: Fer4+Fer4_7 | F: | ECOD (20:10:01) |
| B | | e5t1kB1 | A: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | X: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | H: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | T: Fer4+Fer4_7 | F: | ECOD (20:10:01) |
| C | | e5t1kC1 | A: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | X: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | H: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | T: Fer4+Fer4_7 | F: | ECOD (20:10:01) |
| A | | e5t1kA1 | A: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | X: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | H: Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 | T: Fer4+Fer4_7 | F: | ECOD (20:10:01) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | Cetuximab Fab | VH-CH1 | Chimeric (chimeric) | IGHV2-2*03, IGHJ3*01, IGHG1*03 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202609-0) |
| | Cetuximab Fab | VH-CH1 | Chimeric (chimeric) | IGHV2-2*03, IGHJ3*01, IGHG1*03 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202609-0) |
| | Cetuximab Fab | L-KAPPA | Chimeric (chimeric) | IGKV5-48*01, IGKJ5*01, IGKJ2-3*01, IGKJ2-1*01, IGKJ2-2*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202609-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Heavy Chain | IGHV2 | - | - | SAbDab (2026-03-13) |
| | Heavy Chain | IGHV2 | - | - | SAbDab (2026-03-13) |
| | Light Chain | IGKV5 | Kappa | - | SAbDab (2026-03-13) |
| Chain | Name | Target | Provenance Source |
|---|
| Cetuximab | EGFR/ERBB1/HER1, ERBB3/HER3 | Therapeutic SAbDab (2026-03-13) |
| Ficerafusp | EGFR/ERBB1/HER1, ERBB3/HER3 | Therapeutic SAbDab (2026-03-13) |
Protein Modification Annotation
| Modified Residue(s) |
|---|
| Chain | Residue(s) | Description |
|---|
| | 2GX | Parent Component: PHE
|
| | PCA | Parent Component: GLN
RESID:  AA0031
PSI-MOD :  2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420 |